Characteristics and Outcomes of Direct-Acting Antiviral Experienced Patients with Hepatitis C Undergoing Retreatment at an Essential Hospital in the United States
Outcomes with first-line DAAs were comparable to rescue medications for retreatment of patients with DAA experience and an indeterminate prior treatment outcome. Our findings can help decrease treatment-level barriers for HCV treatment.
Authors
- Alejandro De la Hoz (ORCID: https://orcid.org/0000-0002-9073-1258)
- Glorimar Ruiz-Mercado (ORCID: https://orcid.org/0000-0003-1769-6094)
- Marielle Baldwin (ORCID: https://orcid.org/0000-0001-7111-0344)
- Jessica L. Taylor (ORCID: https://orcid.org/0000-0001-5256-0796)
- Anna Kancharla
- Elissa M. Schechter‐Perkins (ORCID: https://orcid.org/0000-0003-1798-9663)
- David Nunes
- Aiusee Nasreen Pooja
Institutions
- Boston University (US)
- Boston Medical Center (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1093/ofid/ofae704
- Citations
- 1
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.37
Funders
- OPEC Fund for International Development
- Gilead Sciences